CLVS logo

Clovis Oncology (CLVS) Depreciation And Amortization

Annual D&A

$8.50 M
+$298.00 K+3.64%

December 31, 2021

Summary

Performance

1-Year Change

+3.64%

3-Year Change

+84.66%

5-Year Change

+239.3%

15-Year Change

+239.3%

CLVS Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$8.50 M
CLVS annual depreciation & amortization is currently at an all-time high

3-Year Low

$8.50 M
CLVS annual depreciation & amortization is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
CLVS previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
CLVS next annual earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$369.05 M
CLVS annual total expenses is $369.05 million

Annual Operating Expenses

$330.22 M
CLVS annual total operating expenses is $330.22 million

Annual Cost Of Goods Sold

$38.83 M
CLVS annual cost of goods sold is $38.83 million

Annual Interest Expense

$31.67 M
CLVS annual interest expense is $31.67 million

Quarterly D&A

$1.89 M
-$15.00 K-0.79%

September 30, 2022

Summary

Performance

3-Month Change

-0.79%

1-Year Change

-6.53%

3-Year Change

-9.88%

5-Year Change

+199.68%

CLVS Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$3.48 M
CLVS quarterly depreciation & amortization is currently -45.70% below its historical high of $3.48 million

3-Year Low

$1.89 M
CLVS quarterly depreciation & amortization is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
CLVS previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
CLVS next earnings announcement has not yet been scheduled

Related metrics

Quarterly Total Expenses

$74.90 M
CLVS quarterly total expenses is $74.90 million

Quarterly Operating Expenses

$66.29 M
CLVS quarterly total operating expenses is $66.29 million

Quarterly Cost Of Goods Sold

$8.61 M
CLVS quarterly cost of goods sold is $8.61 million

Quarterly Interest Expense

$9.30 M
CLVS quarterly interest expense is $9.30 million

TTM D&A

$7.71 M
-$132.00 K-1.68%

September 30, 2022

Summary

Performance

3-Month Change

-1.68%

1-Year Change

-9.79%

3-Year Change

-0.72%

5-Year Change

-0.72%

CLVS TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$8.55 M
CLVS TTM depreciation & amortization is currently -9.79% below its historical high of $8.55 million

3-Year Low

$7.71 M
CLVS TTM depreciation & amortization is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
CLVS previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
CLVS next earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$369.05 M
CLVS annual total expenses is $369.05 million

Annual Operating Expenses

$330.22 M
CLVS annual total operating expenses is $330.22 million

TTM Cost Of Goods Sold

$36.97 M
CLVS TTM cost of goods sold is $36.97 million

TTM Interest Expense

$34.91 M
CLVS TTM interest expense is $34.91 million

CLVS Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+3.6%-6.5%-9.8%
3 y3 years+84.7%-9.9%-0.7%
5 y5 years+239.3%+199.7%-0.7%

CLVS Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low-5.5%at low-9.2%at low
5 y5-yearat high-8.6%-15.8%at low-9.8%at low
alltimeall timeat high-99.0%-45.7%-272.5%-9.8%-137.1%

Clovis Oncology Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sep 2022
-
$1.89 M(-0.8%)
$7.71 M(-1.7%)
Jun 2022
-
$1.90 M(-1.0%)
$7.84 M(-4.1%)
Mar 2022
-
$1.92 M(-3.8%)
$8.18 M(-3.7%)
Dec 2021
$8.50 M(+3.6%)
$2.00 M(-1.1%)
$8.50 M(-0.6%)
Sep 2021
-
$2.02 M(-9.7%)
$8.55 M(+0.0%)
Jun 2021
-
$2.24 M(-0.2%)
$8.55 M(+2.9%)
Mar 2021
-
$2.24 M(+9.3%)
$8.31 M(+1.4%)
Dec 2020
$8.20 M(+5.5%)
$2.05 M(+1.6%)
$8.20 M(+0.1%)
Sep 2020
-
$2.02 M(+1.1%)
$8.19 M(-0.9%)
Jun 2020
-
$2.00 M(-6.2%)
$8.26 M(+1.1%)
Mar 2020
-
$2.13 M(+4.4%)
$8.18 M(+5.3%)
Dec 2019
$7.77 M(+68.8%)
$2.04 M(-2.6%)
$7.77 M(-0.8%)
Sep 2019
-
$2.10 M(+9.7%)
$7.83 M(+16.4%)
Jun 2019
-
$1.91 M(+10.9%)
$6.73 M(+17.2%)
Mar 2019
-
$1.72 M(-18.2%)
$5.74 M(+24.7%)
Dec 2018
$4.60 M(+83.7%)
$2.10 M(+112.5%)
$4.60 M(+48.9%)
Sep 2018
-
$990.00 K(+7.5%)
$3.09 M(+13.2%)
Jun 2018
-
$921.00 K(+57.2%)
$2.73 M(+11.4%)
Mar 2018
-
$586.00 K(-1.2%)
$2.45 M(-2.1%)
Dec 2017
$2.50 M(+119.5%)
$593.00 K(-5.9%)
$2.50 M(+12.1%)
Sep 2017
-
$630.00 K(-1.9%)
$2.23 M(+19.3%)
Jun 2017
-
$642.00 K(+0.5%)
$1.87 M(+24.0%)
Mar 2017
-
$639.00 K(+98.4%)
$1.51 M(+32.3%)
Dec 2016
$1.14 M
$322.00 K(+19.7%)
$1.14 M(+10.6%)
Sep 2016
-
$269.00 K(-3.9%)
$1.03 M(+7.5%)
DateAnnualQuarterlyTTM
Jun 2016
-
$280.00 K(+3.7%)
$960.00 K(+11.4%)
Mar 2016
-
$270.00 K(+26.8%)
$862.00 K(+13.3%)
Dec 2015
$761.00 K(+71.4%)
$213.00 K(+8.1%)
$761.00 K(-128.1%)
Sep 2015
-
$197.00 K(+8.2%)
-$2.71 M(-2.0%)
Jun 2015
-
$182.00 K(+7.7%)
-$2.76 M(-3.6%)
Mar 2015
-
$169.00 K(-105.2%)
-$2.86 M(-745.0%)
Dec 2014
$444.00 K(+77.6%)
-$3.26 M(-2376.9%)
$444.00 K(-88.2%)
Sep 2014
-
$143.00 K(+78.8%)
$3.77 M(+2.2%)
Jun 2014
-
$80.00 K(-97.7%)
$3.68 M(+0.5%)
Mar 2014
-
$3.48 M(+5249.2%)
$3.67 M(+1366.0%)
Dec 2013
$250.00 K(-29.2%)
$65.00 K(+4.8%)
$250.00 K(-7.1%)
Sep 2013
-
$62.00 K(+1.6%)
$269.00 K(-10.3%)
Jun 2013
-
$61.00 K(-1.6%)
$300.00 K(-9.4%)
Mar 2013
-
$62.00 K(-26.2%)
$331.00 K(-6.2%)
Dec 2012
$353.00 K(+90.8%)
$84.00 K(-9.7%)
$353.00 K(+10.0%)
Sep 2012
-
$93.00 K(+1.1%)
$321.00 K(+16.7%)
Jun 2012
-
$92.00 K(+9.5%)
$275.00 K(+21.1%)
Mar 2012
-
$84.00 K(+61.5%)
$227.00 K(+22.7%)
Dec 2011
$185.00 K(+122.9%)
$52.00 K(+10.6%)
$185.00 K(+14.9%)
Sep 2011
-
$47.00 K(+6.8%)
$161.00 K(+16.7%)
Jun 2011
-
$44.00 K(+4.8%)
$138.00 K(+22.1%)
Mar 2011
-
$42.00 K(+50.0%)
$113.00 K(+36.1%)
Dec 2010
$83.00 K
$28.00 K(+16.7%)
$83.00 K(+50.9%)
Sep 2010
-
$24.00 K(+26.3%)
$55.00 K(+77.4%)
Jun 2010
-
$19.00 K(+58.3%)
$31.00 K(+158.3%)
Mar 2010
-
$12.00 K
$12.00 K

FAQ

  • What is Clovis Oncology annual depreciation & amortization?
  • What is the all time high annual D&A for Clovis Oncology?
  • What is Clovis Oncology annual D&A year-on-year change?
  • What is Clovis Oncology quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Clovis Oncology?
  • What is Clovis Oncology quarterly D&A year-on-year change?
  • What is Clovis Oncology TTM depreciation & amortization?
  • What is the all time high TTM D&A for Clovis Oncology?
  • What is Clovis Oncology TTM D&A year-on-year change?

What is Clovis Oncology annual depreciation & amortization?

The current annual D&A of CLVS is $8.50 M

What is the all time high annual D&A for Clovis Oncology?

Clovis Oncology all-time high annual depreciation & amortization is $8.50 M

What is Clovis Oncology annual D&A year-on-year change?

Over the past year, CLVS annual depreciation & amortization has changed by +$298.00 K (+3.64%)

What is Clovis Oncology quarterly depreciation & amortization?

The current quarterly D&A of CLVS is $1.89 M

What is the all time high quarterly D&A for Clovis Oncology?

Clovis Oncology all-time high quarterly depreciation & amortization is $3.48 M

What is Clovis Oncology quarterly D&A year-on-year change?

Over the past year, CLVS quarterly depreciation & amortization has changed by -$132.00 K (-6.53%)

What is Clovis Oncology TTM depreciation & amortization?

The current TTM D&A of CLVS is $7.71 M

What is the all time high TTM D&A for Clovis Oncology?

Clovis Oncology all-time high TTM depreciation & amortization is $8.55 M

What is Clovis Oncology TTM D&A year-on-year change?

Over the past year, CLVS TTM depreciation & amortization has changed by -$837.00 K (-9.79%)